This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Oncotartis Inc., Health Research, Inc.. Active years: 2002-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2020
Title: The Innovations of Slavoljub Vujcic
Introduction
Slavoljub Vujcic is a notable inventor based in Amherst, NY, who has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, he has focused on developing compounds that have the potential to treat serious health conditions, including various types of cancers.
Latest Patents
Vujcic's latest patents include innovative benzamide and nicotinamide compounds, along with methods for their use. These compounds are particularly promising for treating hematopoietic cancers, such as leukemia. The patents detail the pharmaceutical applications of these compounds, emphasizing their effectiveness in cancer treatment. The preferred compounds feature a phenylethynyl moiety combined with an amine-based heterocyclyl or heteroaryl moiety, enhancing their therapeutic potential.
Career Highlights
Throughout his career, Slavoljub Vujcic has worked with reputable organizations, including Oncotartis Inc. and Health Research, Inc. His work has been instrumental in advancing cancer treatment options, showcasing his dedication to improving patient outcomes through innovative research.
Collaborations
Vujcic has collaborated with esteemed colleagues, including Alexander Polinsky and Lioubov Korotchkina. These partnerships have contributed to the development of his groundbreaking patents and have fostered a collaborative environment for research and innovation.
Conclusion
Slavoljub Vujcic's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his role as an influential inventor. His innovative compounds and collaborative efforts continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile